XCUR

Exicure (XCUR)

About Exicure (XCUR)

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The firm's product pipeline includes Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Redwood City, CA.

Details

Daily high

$4.36

Daily low

$3.82

Price at open

$4.01

52 Week High

$15.91

52 Week Low

$3.10

Market cap

25.7M

Dividend yield

0.00%

Volume

107,237

Avg. volume

50,644

P/E ratio

-2.68

Exicure News